Development
E
Cardlytics, Inc. CDLX
$1.79 $0.116.55% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2023 09/30/2023
Revenue 12.86% 3.00%
Total Other Revenue -- --
Total Revenue 12.86% 3.00%
Cost of Revenue 15.11% -6.56%
Gross Profit 10.16% 17.48%
SG&A Expenses -5.75% -5.59%
Depreciation & Amortization 11.77% -16.81%
Other Operating Expenses -- --
Total Operating Expenses 6.13% -8.44%
Operating Income 37.12% 46.58%
Income Before Tax -320.75% -1.95%
Income Tax Expenses -- --
Earnings from Continuing Operations -320.75% -1.95%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -320.75% -1.95%
EBIT 37.12% 46.58%
EBITDA 83.58% 60.14%
EPS Basic -305.04% 6.38%
Normalized Basic EPS 65.19% 35.43%
EPS Diluted -305.59% 6.38%
Normalized Diluted EPS 65.19% 35.43%
Average Basic Shares Outstanding 3.88% 8.89%
Average Diluted Shares Outstanding 3.88% 8.89%
Dividend Per Share -- --
Payout Ratio -- --